Remembering Three Men Lost to Stomach Cancer
Stomach cancer has robbed Trine Kirkegaard Simpson, Nadia De Giuseppe and Gillian Worden of the men they love, with each woman explaining their loss in our moving video below to raise awareness about the fifth most common cancer in the world.
In Australia, it’s estimated that 2,246 people will be diagnosed with stomach cancer in 2020. That’s 1,817 Australians already diagnosed this year. Stomach cancer is swift, fatal and claims two out of every three lives it affects.
Stomach cancer strikes down twice as many men as women, and the early symptoms, such as bloating, nausea, tiredness or heartburn, can be subtle and easy to ignore.
The month of November is dedicated to raising awareness of the urgent need for more research and clinical trials to create better treatment outcomes.
About the GI Cancer Institute
The GI Cancer Institute is a leading organisation developing and delivering clinical trials and research that explore new treatment options for gastro-intestinal cancer patients here in Australia – ultimately with a view to changing the standard of treatment for all patients to improve both quality of life and life-expectancy.
GI cancer affects the digestive tract – which includes: oesophagus, stomach, liver, gallbladder, biliary tract, pancreas, large and small bowel, rectum and anus. Together these cancers are the most common form of cancer, with 28,600 Australians diagnosed every year and claiming a devastating 39 lives a day. Current five year survival is only 51% for all GI cancers, and is as low as 10.7% for pancreatic cancer.
The GI Cancer Institute works to raise funds and awareness of GI cancer and clinical trials, and through its AGITG members it develops and delivers rigorous best practice clinical trials for gastro-intestinal cancer patients.
The AGITG members, who conduct trials in hospitals right around Australia, include a wide range of medical specialists, scientists, nurses, allied health professionals and consumers involved in all aspects of Gastro-Intestinal cancer research.
All donations are tax deductible and money raised by the GI Cancer Institute funds clinical trials. This research helps improve treatment, raising the life expectancy and quality of life for people diagnosed with digestive cancers.